<--- Back to Details
First PageDocument Content
Biology / Cell biology / Immune system / Fc receptors / Proteins / Cell signaling / Immunoglobulin E / FCER1 / Mast cell / Histamine / Cell surface receptor / Degranulation
Date: 2013-05-03 14:01:30
Biology
Cell biology
Immune system
Fc receptors
Proteins
Cell signaling
Immunoglobulin E
FCER1
Mast cell
Histamine
Cell surface receptor
Degranulation

FEBS Letters–421 journal homepage: www.FEBSLetters.org Single-particle tracking of immunoglobulin E receptors (FceRI) in micron-sized clusters and receptor patches

Add to Reading List

Source URL: stmc.health.unm.edu

Download Document from Source Website

File Size: 541,75 KB

Share Document on Facebook

Similar Documents

Curing Allergic Diseases S-TARget therapeutics GmbH Mooslackengasse 17, 1190 Vienna, Austria. Phone:+, +, +Confidential

Curing Allergic Diseases S-TARget therapeutics GmbH Mooslackengasse 17, 1190 Vienna, Austria. Phone:+, +, +Confidential

DocID: 1rgTJ - View Document

SuppreMol_Crawford Release ENG_Mar 4, 2015

SuppreMol_Crawford Release ENG_Mar 4, 2015

DocID: 1qGKf - View Document

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor &alpha; antibody, in a phase I study of patients with mild asthma

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor &alpha; antibody, in a phase I study of patients with mild asthma

DocID: 1qDqa - View Document

KASCHE & PARTNER AG INTELLECTUAL PROPERTY Dr. André Kasche  Dr. Oliver Horlacher

KASCHE & PARTNER AG INTELLECTUAL PROPERTY Dr. André Kasche Dr. Oliver Horlacher

DocID: 1qxAK - View Document

Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes

Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes

DocID: 1qs00 - View Document